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Smnmary 
Heat-shock proteins have been shown to be critical antigens in a number of autoimmune diseases. 
In human arthritis and in experimentally induced arthritis in animals, disease development was 
seen to coincide with development of immune reactivity directed against not only bacterial hsp60, 
but also against its mammalian homologue. We have developed murine monodonal antibodies 
after immunization with recombinant human hsp60. Antibodies with unique specificity for 
mammalian hsp60, not crossreactive  with the bacterial  counterpart (LK1), and antibodies  recognizing 
both human and bacterial hsp60 (LK2) were selected. Both antibodies recognize epitopes located 
between amino acid positions 383 and 447 of human hsp60. In immunogold  dectron microscopy, 
the mitochondrial localization of hsp60 in HepG2 cells was shown. Furthermore,  both LK1 
and LK2 showed a raised level of staining in light microscopy immunohistochemistry  of synovial 
membranes in patients with juvenile chronic arthritis.  The increased staining for LK1, with a 
unique specificity for mammalian hsp60, thus unequivocally demonstrates that this is due to 
a raised level of expression of endogenously produced host hsp60 and not to deposition of  bacterial 
antigens. 
H 
'eat-shock proteins (hsp) are induced in prokaryotic and 
eukaryotic spedes under various conditions of stress (1, 
2). The hsp's are grouped into families of homologous pro- 
reins based on their molecular masses. The 60-kD hsp family, 
which retained a uniquely high level of sequence conserva- 
tion during evolution (3), is a focus of interest as a potential 
antigen in autoimmune diseases. The experimental model of 
adjuvant arthritis (AA) has provided the initial evidence for 
an important role of hsp60 in the pathogenesis of autoim- 
mune disorders (4-6). In this model, arthritis is induced by 
immunization with heat-kiUed Mycobacterium tuberculosis in 
oil The mycobacterial hsp60 tax'ned out to be the antigen 
recognized by T cell dories that could transfer disease into 
naive animals (4, 5). There is now experimental evidence that 
responses to hsp60 are subject to regulatory T cell control 
(6). This may explain the observation that preimmunization 
with mycobacterial hsp60 induces protection against sub- 
sequent development of AA (4, 7), as well as arthritis  in- 
duced by streptococcal cell walls (8), type II collagen (9), 
or pristane (10). 
These data from experimental animal models have stimu- 
lated the search for T cell reactivity against the mycobacterial 
hsp60 in the synovial fluid (SF) of patients with active ar- 
thritis (11-13). It has been suggested that T cell reactivity 
is directed, at least partly, against the mammalian endoge- 
nous hsp. 
A human mitochondrial protein, originally designated Pl, 
has been described as the human homologue of the mycobac- 
terial hsp60 (14, 15), and >45% of the protein has sequence 
identity with its bacterial homologue. Recently, we have suc- 
ceeded in producing substantial amounts of the human 60- 
kD homologne  by expression  of the gene in Escherichia  coli (16). 
Compelling evidence for  T  cell  recognition of "self- 
endogenous hsp" comes from a study from Hermann et al. 
(17). They showed that from the  joint of a patient with reac- 
tive arthritis after infection with Ye~inia enterocolitica, a Ye~inia- 
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reactive  with recombinant human hsp60  as  well as with 
heat-stressed  autologous cells. Also, T  cells obtained from 
SF of  children with  juvenile chronic arthritis (JCA) responded 
to the human hsp60 (16). 
Previous studies, using anti-mycobacterial hsp60 antibodies 
that are crossreactive with human hsp60, have shown increased 
expression of hsp60 in inflamed tissue (16-20).  However, be- 
cause of this crossreactivity,  it was impossible to distinguish 
between the expression of hsp60 from bacterial origin (e.g., 
after a bacterial infection) or endogenous self-hsp60.  To re- 
solve this issue we have set out to generate mAbs with unique 
specificity for human hsp60. In the present study we describe 
the characterization  of two murine mAbs called LK1 and LK2 
derived from mice immunized with recombinant human 
hsp60. LK1 is only specific for mammalian hsp60, while LK2 
shows crossreactivity with bacterial hsp60. Synovial biopsies 
from patients with JCA stained with LK1 and LK2 revealed 
an increased hsp60 expression  in these patients as compared 
with controls. Because of the unique specificity of LK1 for 
mammalian hsp60, these findings have demonstrated a raised 
synthesis of self-hsp60 in lining cells of the inflamed synovium. 
Materials and Methods 
Antigens.  The human hsp60 gene was obtained from Dr. R. A. 
Young (Whitehead Institute, Cambridge, MA) as a phage X-gt11 
done from a cDNA library prepared from Hela cells by Dr. R. S. 
Gupta (Health Science Centre, Hamilton, Ontario, Canada) (14). 
Through intermediate pEX2-derived plasmids, an SphI restriction 
site was introduced at the position of the start codon, resulting 
in plasmid pRH710 expressing the complete human hsp60 as a 
B-galactosidase fusion protein. The gene was then subdoned as 
an SphI/HindlII fragment into vector pRH901. The HindlII site 
downstream of the gene originated from pEX2. pKH901 was con- 
structed from expression vector pNGS20(+) by Sail digestion fol- 
lowed by filling in with T4 polymerase  to adjust the reading frame 
close before the SphI site in the multiple cloning region. Subcloning 
of the human hsp60 gene into pRH901 thus resulted in plasmid 
pRH1011, from which hsp60, preceded  by a short leader sequence 
of 31 amino acid residues derived from the cloning vector, could 
be expressed with isopropyl-b-I~-thiogalactopyranoside  (IPTG) in- 
duction (17). 
Deletion mutants of  human hsp60 were constructed  from phsmid 
pRIq710. Followed  by religation, fragments of the hsp60 gene were 
deleted by cleavage  with NsiI/PstI (resulting in plasmid pRH2002 
expressing residues 1-447), with EcotLI (pRH2012: 238-573; and 
plLH2015: 1-239), with StyI (pRH2026:  1-125/450-573;  and 
pRH2028:l-125), and with SpeI (pRH2030: 1-383). Phsmid pLucl 
(residues 356-531) was  obtained by Taq-polymerase-facilitated 
amplification of the corresponding DNA sequence using primers 
containing restriction sites to allow cloning of the fragment into 
expression vector pEX2. All constructs were checked  by sequencing. 
The B-galactosidase  fusion  proteins were obtained  from recombinant 
E. coli strains as described (4). 
The recombinant hsp65 protein of Mycobacterium boris BCG was 
prepared after expression from plasmid pRIB1300 and purified as 
previously  described (4, 21). Deletion mutants of the mycobacterial 
hsp65 were prepared as described (4). 
Cell extracts of  different bacterial strains were obtained as previ- 
ously described (22). The strains used are Boreltia, E. coli, Strep- 
tococcus l:~ogenes,  Yersinia entercolitica, Salmonella  typhirauriura, 
Treponema hyodysenteriae, and Treponema innocense. A crude extract 
of Trichinella spiralis was obtained as previously described (23). 
mAb Production.  Mice  (BALB/c  females; Iffa Credo-Broekman 
B. V., Brussds, Belgium) were immunized with 100 #1 of 1 mg/ml 
recombinant human hsp60 in PBS mixed with 100 #1 mono- 
phosphoryl lipid A+trehalose  dimycolate emulsion (Ribi;  Im- 
munoChem Research, Inc.) intraperitoneally. 2 mo after immuni- 
zation, the mice were boosted intravenously with 50 #g human 
hsp60 in PBS. After 4 d, spleen cells were fused with mouse my- 
eloma cells (Sp2/0) using polyethylene glycol 4000. Anti-hsp60 
and anti-mycobacterial  hsp60 antibody producing hybridomas  were 
selected by ELISA (24) and Western blotting,  and subcloned in 
limiting dilution. 
SDS/PAGE and Imraunoblotting.  Cell extracts of either ver- 
tebrate or bacterial cells were made in Laemmli buffer containing 
~/-mercaptoethanol, and equivalent amounts of protein (0.5 #g) 
from various extracts were subjected  to electrophoresis  in 10% SDS 
gels, as described earlier (22, 25). Electrophoretic transfer of pro- 
teins from polyacrylamide  gds to nitrocellulose  sheets was performed 
as described (25). The blots were blocked with 0.5% Tween 20 
in saline (10 mM Tris hydrochloride, pH 7.4, 155 mM NaC1) and 
subsequently  treated with second  antibodies and their corresponding 
horseradish peroxidase second antibodies. Binding of the conjugate 
was  visualized by  using  dioctyl  sodium  sulfasuccinate/tetra- 
methylbenzidine  (DONS/TMB) in 0.01 M dtrate phosphate  buffer, 
pH 5, and hydrogen peroxide 0.02%. 
Immunoelectron Microscol~.  Cells  from the human hepatoma cell 
line HEPG2 were fixed in a mixture of 2% paraformaldehyde  and 
1% acrolein in 0.1 M phosphate buffer, pH 7.4, for 24 h at 37~ 
Ultrathin cryosections were immunogold labeled for the demon- 
stration of hsp60 as previously  described  by Slot et al. (26). Briefly, 
after fixation, cells were washed with PBS, containing 0.15 M gly- 
cine. After embedding in 10% gelatin, the gelatin slab was kept 
at 4~  Small  pieces of gelatin were infiltrated with 2.3 M sucrose 
and mounted at 4~  Ultrathin  cryosections were immunogold 
labeled with mouse mAb LK1 or LK2, and control mAb (K73: 
mouse anti-rat TCR.) and 10-nm gold particles, complexed to pro- 
tein A. Rabbit anti-mouse Ig (HPLC purified, kindly provided by 
Dr. J. Borst, Netherlands Cancer Institute, Amsterdam) was used 
as an intermediate step between the mAb and the gold probe. Sec- 
tions were examined with an electron microscope at 80 kV (1200 
EX; Jeol). 
Histology and lramunohistochemistry.  For immunohistochemistry, 
a synovial biopsy of a patient with JCA and a non-JCA control 
were used. The patient had an oligoarticular  onset of  JCA, as defined 
by the European League Against Rheumatism. The duration of 
the disease was 2.0 yr and the duration of the current arthritis was 
0.4 yr. As a control, a patient with persistent arthralgia was used. 
In the case  of the JCA patient, the synovial  membrane  biopsy sample 
was taken in a phase of active arthritis during arthroscopy of the 
knee. The synovial  biopsy sample of the control was taken during 
arthroscopy as well, for diagnostic reasons. For histology, part of 
the samples  was fixed  in buffered  formalin,  and embedded  in paraffin. 
Sections of 8 #m were stained with hematoxylin and eosin. The 
sections were reviewed histologically for the degree of synovitis: 
mild synovitis in case of the JCA patient and absent synovitis in 
case of the control. For immunohistochemistry another part was 
snap-frozen and stored at  -700C until analysis. For detection of 
human hsp60 or related molecules,  LK1 (1:250) and LK2 (1:1,000) 
were used. In addition, an anti-HLA-DK mAb was applied as a 
positive control (Becton Dickinson & Co., Mountain View, CA). 
Staining with a nonrelevant monodonal of the same isotype (K73) 
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of  LKland LK2 mAbs.  Cell  extracts 
from various bacterial species  were 
subjected  to electrophoresis  in SDS- 
polyacrylamide gels and  blotted 
onto nitrocellulose, and crossreac- 
tivity to LK1 and LK2 mAbs was 
examined. (.4) mAb LKI: cell ex- 
tract or antigen. Lane  1, Trichinella 
sp/ral/s crude extract (500 ng); lane 
2, Tre/,onema  ~ocence  (500  ng); lane 
3, Yre/antema  hyodTsenter/a  (500  ng); 
lane 4, Salmonella t,/phimurium (500 
ng); lane 5, Yeninia  enterolitica (500 
ng); lane 6, E. coli (500 ng); lane 
7, recombinant mycobacterial  hsp60 
(100 ng); lane 8, control pRH901 
(100 ng); and lane 9; recombinant 
human hsp60 (100 ng). (B) mAb 
LK2: cell  extracts  or antigens, as de- 
scribed in A, lanes I-9. (C) mAb 
LK2: human hsp60 deletion mu- 
tants (lanes I and 2) and mycobac- 
terial hsp65 deletion  mutants (lanes 
3-10).  Lane 1, pRH2012 (amino 
acid [aa] residue 238-573, human 
hsp60); lane 2, pRH710  (aa residue 
1-573,  human hsp60); lane  3, 
pEX-2 control; lane 4, pRIB 1463 
(aa residue  404-540, myeobacterial  hspt0); lane 5, plLIB 1444  (aa residue  303-540, myr.obacterial  hsp60); lane  6, pRIB1451  (aa residue  276-540, myr.obacterial 
hsp60); lane 7, pRIB 1426 (aa residue 171-540, mycobacterial  hsp60; lane 8, pRIB 1422 (aa residue 109-540, mycobacterial  hsp60); lane 9, pRIB 
1424 (aa residue  84-540); lane 10, pRIB 1404 (aa residue -2-540).  (D) mAb LKI: human hsp60 deletion  mutants. Lane  I, pRH710 (aa residue 1-573); 
lane 2, pRH2012 (aa residue 238-573); lane 3, pRH2026 (aa residues 1-124 and 450--573); lane 4, pRH2002 (aa residue 1-447); lane 5, pRH2015 
(aa residue 0-239); lane 6, pRH2028 (aa residue 1-125); and lane 7, pEX-2 control. 
and staining without applying a first antibody served as negative 
control. Frozen tissue sections of 9/zm were fixed in acetone. A 
three-step indirect  immunoperoxidase  method was applied using 
a first incubation  with mAb, followed by rabbit Igs to mouse Igs 
conjugated to horseradish peroxidase in the second step, and swine 
Igs to rabbit Igs conjugated  to horseradish peroxidase in the third 
step (antibodies from Dakopatts, Glostrup, Denmark). Staining was 
performed  using  3-3'  diaminobenzidine  tetrahydrochloride  with 
hydrogen peroxidase as substrate. The sections were counterstained 
with hematoxylin. 
Results  and  Discuuion 
Isolation and Specificity of  mAbs LK1 and LK2.  Several hy- 
hridoma cell culture supernatants were screened for binding 
to the recombinant human hsp60 as well as to the mycohac- 
terial hsp60. We selected and subcloned hyhridomas by lim- 
iting  dilution  and have characterized  in depth  two mAbs, 
LK1 and LK2. These mAbs were examined on Western blots. 
Part of the results of these studies  are presented in Fig.  1. 
As can be seen, the LK1 antibody only reacts with recom- 
binant human hsp60 (Fig.  1 A, lane 9), while the LK2 anti- 
body also showed reactivity with recombinant mycobacterial 
hsp60 as well as corresponding proteins (e.g., groEL protein 
of E.  coli; Fig.  1 B, lane 6) present in cell extracts of other 
bacteria and helminths (Fig.  1 B, lanes I-9). Because of more 
downstream internal initiation points, human hsp60 transla- 
tion products of different sizes were obtained (Fig.  1, a and 
b, lanes 9). In immunoblots with whole mammalian cell ex- 
tracts, LK1 and LK2 reacted with a single 60-kD band only 
(data not shown). Thug no crossreactivity with other human 
proteins was found. LK2 also showed a strong reaction when 
tested on extracts of yeast and spinach chloroplasts (data not 
shown). Subsequently, we tested the mAbs on the pEX dele- 
tion mutants from mycobacterial hsp60 or human hsp60 in 
an immunoblot. As can be seen in Fig. 1 C, LK2 recognizes 
mycobacterial hsp60 protein fragments that lacked the amino 
acids up to residue 303 (see pRIB  1444;  Fig.  1 C,  lane 5), 
but deletions extending to amino acid 404 (pRIB 1463; Fig. 
1 C, lane 4) showed no reactivity. A  fragment with a dele- 
tion extended to amino acid 390 (plkIB 1456) was found to 
be negative (data not shown).  Also, deletion mutants from 
human  hsp60 were tested,  and in Fig.  1 D,  the results are 
shown for LK1 reactivity. The reaction pattern obtained with 
LK2 was completely identical to that of LK1, indicating that 
the epitope(s) recognized by LK1 and LK2 are formed by 
amino acid residues within the sequence 238-447 of the human 
hsp60. Recently, we made two more deletion mutants of the 
human hsp60. Only Lucl (amino acid residues 356-531) was 
recognized by both LK1 and LK2, whereas pRH2030 (amino 
acid residues  1-383)  was not  (data  not  shown).  Taken  to- 
gether, these data indicate that the epitope recognized by LK1 
is located between amino acid positions 383 and 447 of the 
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Immunogold labeling of hsp60 in ultrathin cryosections 
of fixed HepG2 cells. (A) Section labeled with control 
K73 isotype-identical  irrelevant mAb. The mitochondria 
show no label. Only one background particle can be seen, 
The mitochondria are negative,  x51,000.  (/3) Section la- 
baled with LK1 antibody. The mitochondria show abun- 
dant labeling for human hsp60,  x 55,200. 
human sequence. The epitope recognized by LK2 is located 
between amino acid residues 383 and 419 of the human hsp60 
sequence  (which  corresponds  with  amino  acid  residues 
356-393  of the mycobacterial hsp60 sequence). Because the 
LK2 antibody crossreacts with bacterial hsp, this antibody, 
in contrast  to LK1, most probably  reacts to an epitope in 
the molecules that is conserved between bacterial and mam- 
malian hsp. 
Upon examination of the human cell line HepG2 by im- 
munoelectromicroscopy (Fig. 2), LK1 reactivity was observed 
exclusively in the mitochondria (Fig. 2 B). No gold particles 
were observed in other structures. This finding confirms ear- 
lier evidence  for the mitochondrial localization of human hsp60 
(14). No mitochondrial staining was obtained with an isotype- 
matched (3/1) control mAb of irrelevant  specificity (R73; 
rig. 2A). 
The Level  of  Expression of  Human hsp60  Is Raised in Arthritic 
SFu~viura.  Because  of previous reports documenting increased 
staining with anti-mycobacterial hsp60 antibody in inflamed 
tissues (18-20),  we tested LK1 and LK2 in a similar man- 
ner.  Fig.  3  shows  examples of staining  with  the human 
hsp60-specific antibody LK1 in synovial biopsy samples of 
a JCA patient and a non-JCA control child.  A  significant 
difference  in staining intensity was observed between the JCA 
patient and the non-JCA control for LK1, LK2, and HLA- 
DR. (Fig. 3, A-F). No specific staining was observed when 
the primary antibody was omitted or an irrelevant isotype- 
matched first  antibody was used  (Fig.  3,  G  and H).  The 
staining pattern for LK1 and LK2 was cytoplasmic. Positive 
cells were observed in the synovial lining layer, the endothelial 
cells of blood vessels, and cells scattered throughout the in- 
terstitium. However, the staining was most prominent in the 
synovial lining layer. 
One hypothesis for the induction of autoimmune arthritis 
is based on molecular mimicry, first described by Oldstone 
(27).  Epitopes  shared between viral or bacterial  infectious 
agents and self-antigens present in the host are recognized 
by specific cells during the immune response. The ensuing 
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biopsy samples with mAbs LK1,  LK2, and HLA-DR. 
Comparison of a patient with an oligoarticular onset of 
JCA (left) and a non-JCA control child (right).  (.4  and 
B) Sections labeled with LKI: a significant  difference in 
cytoplasmic staining of the synovial lining cells can be ob- 
served in the JCA patient in comparison with the non- 
JCA control child,  x 132. (C and D) Sections hbded with 
LK2: a similar difference in staining pattern as for LK1 
between the JCA patient and the non-JCA control child. 
x 132. (E and F). Sections  labeled with HLA-DR: the 
staining is more ~tensive in the JCA patient than in the 
non-JCA control child,  x 132.  (G and H)  No  specific 
staining is observed in the negative control section (i.e., 
omitting or irrelevant isotype-matched  primary antibody) 
for the JCA patient and non-JCA control child,  x 132. 
crossreactive response results in an attack on the foreign in- 
vader but also on self structures.  Because of their extensive 
evolutionary conservation, heat-shock proteins are likely can- 
didates for such a process and are therefore increasingly men- 
tioned as target antigens in autoimmune diseases (1, 2,  5, 
10). There is already evidence supporting the hypothesis that 
an immune response  originally triggered by bacterial hsp might 
induce hsp-specific T cells that recognize an epitope common 
to bacterial  and self-hsp (2,  5,  17). 
Recently, we documented that T cells from synovial fluid 
of  patients with  JCA showed proliferative responses to human 
hsp60 (16). Whether the presence of such hsp60-specific T 
cells is the consequence of stimulation by locally deposited 
bacterial hsp antigens or by endogenously expressed human 
hsp60 remains to be established. The findings of staining with 
LK1 mAb uniquely specific for mammalian hsp60 on syno- 
vial cells is dearly in support of the latter possibility. To sub- 
stantiate this, follow-up studies are necessary and immuno- 
histochemical measurement of the expression of endogenous 
hsp60 or related molecules using mAbs LK1 and LK2 as well 
as monitoring of the T cell reactivity against human recom- 
binant hsp60 might be important tools  in testing this hy- 
pothesis. 
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